AXIM BIOTECHNOLOGIES, INC.
AXIM · OTCMCIK 1514946fmd_0FBEJCQRRBM3K4VWEZEZJ4TCCKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2011 to Jun 30, 2024, 54 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (3)
- Net income
- (8)
- Free cash flow
- (1)
Latest quarter · Q2 FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (2)
- Free cash flow
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- n/m
- Revenue, 5 yearsFY2018 to FY2023
- -27.4%
- Net income, 5 yearsFY2018 to FY2023
- n/m
AXIM BIOTECHNOLOGIES, INC. (AXIM) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $39,518 | $8,875 | +345.3% | 10-K 2024-04-16 · proof |
| Operating income | -$2.8 million | -$4.7 million | 10-K 2024-04-16 · proof | |
| Net income | -$8.1 million | -$6.2 million | 10-K 2024-04-16 · proof | |
| Cash from operating activities | -$1 million | -$2 million | 10-K 2024-04-16 · proof | |
| Free cash flow | -$1 million | -$2.1 million | 10-K 2024-04-16 · proof | |
| Total assets | $4.1 million | $4.2 million | -2.1% | 10-K 2024-04-16 · proof |
| Total liabilities | $11.8 million | $9 million | +30.3% | 10-K 2024-04-16 · proof |
| Cash and cash equivalents | $156,457 | $47,282 | +230.9% | 10-K 2024-04-16 · proof |
| Total debt | $231,873 | 10-Q 2024-05-20 · proof |
- What was AXIM BIOTECHNOLOGIES, INC. (AXIM)'s revenue in fiscal 2023?
- AXIM BIOTECHNOLOGIES, INC. (AXIM) reported revenue of $39,518 for fiscal 2023 (the year ended Dec 31, 2023), against $8,875 the year before (+345.3%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was AXIM BIOTECHNOLOGIES, INC. (AXIM)'s operating income in fiscal 2023?
- AXIM BIOTECHNOLOGIES, INC. (AXIM) reported operating income of -$2.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$4.7 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was AXIM BIOTECHNOLOGIES, INC. (AXIM)'s net income in fiscal 2023?
- AXIM BIOTECHNOLOGIES, INC. (AXIM) reported net income of -$8.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$6.2 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was AXIM BIOTECHNOLOGIES, INC. (AXIM)'s cash from operating activities in fiscal 2023?
- AXIM BIOTECHNOLOGIES, INC. (AXIM) reported cash from operating activities of -$1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$2 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What was AXIM BIOTECHNOLOGIES, INC. (AXIM)'s free cash flow in fiscal 2023?
- AXIM BIOTECHNOLOGIES, INC. (AXIM) reported free cash flow of -$1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$2.1 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What are AXIM BIOTECHNOLOGIES, INC. (AXIM)'s total assets?
- As of Dec 31, 2023, AXIM BIOTECHNOLOGIES, INC. (AXIM) reported total assets of $4.1 million, against $4.2 million a year earlier (-2.1%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What are AXIM BIOTECHNOLOGIES, INC. (AXIM)'s total liabilities?
- As of Dec 31, 2023, AXIM BIOTECHNOLOGIES, INC. (AXIM) reported total liabilities of $11.8 million, against $9 million a year earlier (+30.3%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What are AXIM BIOTECHNOLOGIES, INC. (AXIM)'s cash and cash equivalents?
- As of Dec 31, 2023, AXIM BIOTECHNOLOGIES, INC. (AXIM) reported cash and cash equivalents of $156,457, against $47,282 a year earlier (+230.9%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
- What is AXIM BIOTECHNOLOGIES, INC. (AXIM)'s total debt?
- As of Dec 31, 2023, AXIM BIOTECHNOLOGIES, INC. (AXIM) reported total debt of $231,873. Source: the 10-Q filed with the SEC on May 20, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:AXIM&period_type=annual&limit=5"Information only, not investment advice.